XENT - Intersect ENT - Stock Forecast

Health Care Equipment & Supplies - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Intersect ENT's activity chart (see below) currently has 75 price targets and 56 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.06% with an average time for these price targets to be met of 161.65 days.

Most recent stock forecast was given by from TRUIST on 11-Aug-2021. First documented stock forecast 18-Aug-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2021

$28.25

$0.01 (0.04%)

$23

5 years 1 months 24 days ago
(11-Aug-2021)

11/13 (84.62%)

$0.67 (2.43%)

119

Buy Since 09-Aug-2021

$28

$-0.24 (-0.85%)

$30

5 years 1 months 26 days ago
(09-Aug-2021)

1/2 (50%)

$0.17 (0.61%)

1

Buy Since 25-Jan-2021

$28.25

5 years 1 months 26 days ago
(09-Aug-2021)

1/8 (12.5%)

$0.88 (3.22%)

2

Hold Since 22-Oct-2020

$23

5 years 4 months 17 days ago
(18-May-2021)

4/4 (100%)

$0.84 (3.79%)

41

Hold Since 15-Oct-2020

$17

$-11.24 (-39.80%)

$17

5 years 11 months 20 days ago
(15-Oct-2020)

14/17 (82.35%)

$-0.7 (-3.95%)

99

Show more analysts

Please expand the browser size to see the chart

What is XENT (Intersect ENT) average time for price targets to be met?

On average it took 162 days for the stock forecasts to be reached, with an average price target met ratio of 74.06%.

Which analyst most recently updated their price target on XENT (Intersect ENT)?

Which analyst has the most public recommendations on XENT (Intersect ENT)?

has 0 price targets and 0 ratings on XENT

Which analyst is the currently most bullish on XENT (Intersect ENT)?

Michael Weinstein with the highest potential upside of $14.76

Which analyst is the currently most reserved on XENT (Intersect ENT)?

Bob Hopkins with the lowest potential downside of -$18.24
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?